does ambetter cover semaglutide Wegovy? A State-by-State Breakdown of What's Actually Covered in 2026 Finding out whether your insurance

There could be a new cheaper challenger to Ozempic coming soon -- and it's made by the same company

Altimmune just made a big move in the world of GLP-1 research, but this time, its not about obesity.The company announced yesterday that it has officially begun enrolling participants in a Phase 2 trial of pemvidutide, its GLP-1 and glucagon dual receptor agonist, to evaluate the drug in people with Alcohol Use Disorder, or AUD

Labs were unremarkable upon admission

Packaging: Sterile, sealed vial for laboratory handling

Leana Wen explains what people should know about the medication.

GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results presented at ASCO Gastrointestinal Cancers Symposium.A retrospective analysis of more than 281,000 people showed those who used GLP-1s exhibited a 36% reduced risk for colorectal cancer compared with those who used aspirin